Schedule 13G ownership disclosure

CTI BIOPHARMA CORP

Security class unavailable · CUSIP: 12648L601

Event date: 2022-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-22-000609
Form type
SC 13G
Filer
CTI BIOPHARMA CORP
CIK
CIK 891293
Filed
Oct 11, 2022
Reporting period
Sep 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub